{"changeSha256":"6d03ed56c08b5e9e9fb6ba8b1f55f29b71aa0d18864f4283af651621015b8503","changedAt":"2026-07-27","changedFields":[{"after":"A glucagon/GLP-1 receptor agonist candidate. This profile cites a ClinicalTrials.gov study record that was active, not recruiting.","before":"A glucagon/GLP-1 receptor agonist candidate represented in ClinicalTrials.gov.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/survodutide/versions/2/","version":2},"id":"profile:survodutide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change.","peptideSlugs":["survodutide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/survodutide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-nct05202353-v50","name":"ClinicalTrials.gov","sourceClass":"A","title":"BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver · record history version 50 · last update posted 2026-07-22","url":"https://clinicaltrials.gov/study/NCT05202353?a=50&tab=history","verifiedAt":"2026-07-22"}],"subject":{"slug":"survodutide","type":"profile"}}